🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07764081
Recruiting Observational

Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms

NCT07764081 · tracked via the Priya Life Science China tracker
Sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Observational
Started
2026-07-31
Last updated
2026-08-13

Condition(s) studied

Coronary Artery DiseaseAneurysmsCoronary Intervention

Study summary

This study aimed to characterize the progression and risk fators of coronary artery aneurysms, and copmpare the outcomes across different management strategies

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Angiographically confirmed coronary artery aneurysm, defined as coronary dilation ≥1.5 times the adjacent normal reference vessel diameter. 2. Age 18-80 years. Exclusion Criteria: 1. Suboptimal image quality 2. Incomplete clinical data, including medical history, laboratory parameters, or follow-up records.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Nanjing First Hospital Nanjing Jiangsu Recruiting

More Nanjing First Hospital, Nanjing Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07764081 on ClinicalTrials.gov ↗ ← All trials in China